LBA23 FOUR-YEAR FOLLOW-UP OF A PHASE-3 PROSPECTIVE RANDOMIZED TRIAL OF VASCULAR-TARGETED PHOTOTHERAPY VERSUS ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER. | Zendy

AI Assistant Blog Pricing

LBA23 FOUR-YEAR FOLLOW-UP OF A PHASE-3 PROSPECTIVE RANDOMIZED TRIAL OF VASCULAR-TARGETED PHOTOTHERAPY VERSUS ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER.

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.